FFC#4/2021

Oxidative stress and autophagy in Cystic Fibrosis: Novel biochemical characterizations and drug discovery approaches

AREA 1 Therapies to correct the underlying defect

FFC#4/2021

Oxidative stress and autophagy in Cystic Fibrosis: Novel biochemical characterizations and drug discovery approaches
€ 0 still needed
0%
€ 104.000 goal

pRINCIPAL INVESTIGATOR

Giorgio Cozza (Dipartimento di Medicina Molecolare, Università di Padova)

Partner

Federica Rossin (Dipartimento di Biologia dell’Università Tor Vergata di Roma)

Researchers

13

Category

AREA 1 Therapies to correct the underlying defect

Duration

2 years

Goal

€ 104.000

Funds raised

€ 104.000

Objectives

This project, an extension of FFC#4/2019, aims to develop new molecules or their combinations capable of restoring the function of CFTR. Thanks to the results of previous projects, the researchers observed that oxidative stress is closely linked to defects in autophagy in cystic fibrosis (CF). Researchers identified a number of molecules capable of restoring CFTR function by balancing the pro-oxidative state in CF models. Thanks also to computational approaches such as Virtual Screening and Pharmacophoric search, the researchers will select molecules and validate their efficacy in both cellular experimental models, such as primary nasal epithelial cells from F508del, N1303K, G85E and R1066C donors and in vivo with transgenic mouse models.

XIX Convention FFC Ricerca – download here a brief presentation of the project

 

WHO ADOPTED THE PROECT

Delegazione FFC Ricerca della Franciacorta e Val Camonica

€ 104.000

Gruppo di sostegno FFC Ricerca Genova “Mamme per la ricerca”

€ 50.000

Delegazione FFC Ricerca di Prato

€ 15.000

OTHER PROJECTS

Discover the other projects

GMSG#1/2025

Developing PNAs to Block Essential Bacterial Genes and Create New Antimicrobial Therapies

FFC#1/2025

Understanding the process of epithelial-mesenchymal transition to preserve tissue function and reduce long-term complications (e.g. cancer)

FFC#2/2025

Developing RNA-targeted therapies to regulate gene expression and restore CFTR synthesis